Dextromethorphan Distribution Act of 2006
Summary
H.R. 5280, the Dextromethorphan Distribution Act of 2006, aims to curb the abuse of the common cough suppressant dextromethorphan (DXM) by restricting access to its raw, unfinished form. The bill would prohibit the distribution of bulk, powdered DXM to anyone other than registered drug manufacturers and medical device producers. For the average citizen, this means that while finished over-the-counter cough medicines remain available at pharmacies, the concentrated raw material used to create high-potency mixtures would be strictly regulated to prevent it from being sold directly to the public.
AI-generated summary
Lifecycle of the Bill
No events recorded for this stage yet.